McDermott + Bull has successfully placed Scott Durbin as Chief Executive Officer at illumiSonics. In this role, Scott will partner with the Board and leadership team to cultivate the strategic vision, streamline the go-to-market strategy, strengthen their world-class team, and prepare the company for expansive growth.

Scott has over 25 years of experience in the life sciences sector working with both startups and multinational companies, adeptly navigating between finance and operational roles. His accomplishments are particularly highlighted by his success in guiding med-tech products and companies from their early stages to full commercialization. Scott’s tenure as a Wall Street-based investment banker with a focus on healthcare and medical products complements his expertise in building strong teams for both public and private entities.

illumiSonics is a privately held medical device company committed to pushing the boundaries of medical imaging technology. As stated by the CEO, “illumiSonics is at the forefront of developing cutting-edge optical imaging solutions that have the potential to address a multitude of therapeutic applications across life sciences and beyond”.

This executive search was completed by McDermott + Bull Partners Dan O’Day and Ken Dropiewski, and Principal Lisa Hunter.